Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: a pilot study.
Consuelo
C
Pérez-Rico
Javier
J
Benítez-Herreros
Maria
M
Castro-Rebollo
Yanira
Y
Gómez-SanGil
Francisco
F
Germain
María Angeles
MA
Montes-Mollón
Miguel Angel
MA
Teus
D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D004728:Endothelium, Corneal / Q000187:drug effects*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies; D000069579:Ranibizumab
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab